ContributorsPublishersAdvertisers

Dr. Leal on Developments Made in EGFR Exon 20–Mutant NSCLC Treatment

onclive.com
 2021-11-24

Ticiana Leal, MD, discusses developments made in the treatment of patients with EGFR exon 20 insertion–mutant non–small cell lung cancer. Ticiana Leal, MD, associate professor, director, Department of Hematology and Medical Oncology, Thoracic Medical Oncology...

www.onclive.com

Comments / 0

Comments / 0